1. Desloratadine not recommended during pregnancy

   News item 01 February 2013 Pages: 2 - 2

2. FDA proposes HT class labelling to include WHI data

   News item 01 February 2013 Pages: 2 - 2

3. Labelling changes for zafirlukast in Canada

   News item 01 February 2013 Pages: 2 - 2

4. Breast cancer risk differs by HRT regimen

   Incidence study 01 February 2013 Pages: 3 - 3

5. Cardioselective β-blockers safe in patients with reactive airway disease?

   Clinical study 01 February 2013 Pages: 3 - 3

6. OCs increase breast cancer risk in BRCA1 mutation carriers

   Incidence study 01 February 2013 Pages: 3 - 3

7. Women stop HRT therapy after risks highlighted

   Media release 01 February 2013 Pages: 3 - 3

8. Neonatal complications following in utero paroxetine exposure

   Incidence study 01 February 2013 Pages: 4 - 4

9. Postpartum misoprostol: more side effects than oxytocin?

   Clinical study 01 February 2013 Pages: 4 - 4

10. Filgrastim: no association with leukaemia development?

    Incidence study 01 February 2013 Pages: 5 - 5

11. Gemfibrozil/cerivastatin interaction examined

    Clinical study 01 February 2013 Pages: 5 - 5

12. Maternal methadone dosage associated with neonatal withdrawal

    Clinical study 01 February 2013 Pages: 5 - 5

13. Reduced exposure time does not decrease cutaneous intolerance to chlormethine

    Clinical study 01 February 2013 Pages: 5 - 5

14. Risperidone: depression and dysphoria in patients with Tourette's syndrome

    Incidence study 01 February 2013 Pages: 5 - 5

15. Alemtuzumab

    Case report 01 February 2013 Pages: 6 - 6

16. Amoxicillin

    Case report 01 February 2013 Pages: 6 - 6

17. BCG

    Case report 01 February 2013 Pages: 6 - 6

18. Cerivastatin

    Case report 01 February 2013 Pages: 6 - 6

19. Corticotropin/sumatriptan

    Case reports 01 February 2013 Pages: 6 - 7

20. Cyclosporin

    Case report 01 February 2013 Pages: 7 - 7

21. Cyclosporin

    Case report 01 February 2013 Pages: 7 - 7

22. Cyclosporin interaction

    Case report 01 February 2013 Pages: 7 - 7

23. Cytarabine/idarubicin

    Case report 01 February 2013 Pages: 7 - 8

24. Fluticasone propionate

    Case report 01 February 2013 Pages: 8 - 8

25. Gentamicin

    Case report 01 February 2013 Pages: 8 - 8

26. Herbal medicines

    Case report 01 February 2013 Pages: 8 - 8

27. Imatinib mesylate

    Case report 01 February 2013 Pages: 8 - 9

28. Indapamide

    Case report 01 February 2013 Pages: 9 - 9

29. Infertility therapies

    Case report 01 February 2013 Pages: 9 - 9

30. Ioxilan

    Case report 01 February 2013 Pages: 9 - 9

31. Lamivudine

    Case report 01 February 2013 Pages: 9 - 9

32. Mirtazapine

    Case report 01 February 2013 Pages: 10 - 10

33. NSAIDs

    Case reports 01 February 2013 Pages: 10 - 10

34. PEG-interferon-α-2a/PEG-interferon-α-2b

    Case reports 01 February 2013 Pages: 10 - 10

35. Pergolide

    Case report 01 February 2013 Pages: 10 - 11

36. Povidone iodine

    Case report 01 February 2013 Pages: 11 - 11

37. Quetiapine interaction

    Case report 01 February 2013 Pages: 11 - 11

38. Reboxetine/tegaserod

    Case reports 01 February 2013 Pages: 11 - 11

39. Sodium stibogluconate

    Case report 01 February 2013 Pages: 11 - 11

40. Terbutaline

    Case report 01 February 2013 Pages: 12 - 12